From Name:
From Email:
To Name:
To Email:

Optional Message:


Pharma Firm Gets FDA Approval For ADHD Drug, More Jobs Likely

from Philadelphia Business Journal

The Food and Drug Administration granted marketing approval to Adzenys XR-ODT, an extended-release product developed by Neos Therapeutics to treat attention-deficit hyperactivity disorder treatment in patients age six and older. Health officials estimated ADHD affects 5 percent of children and 2.5 percent of adults in the United States. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063